设为首页         

资讯内容 Content

[ASH2010]Amlodipine:An Attractive partner---- Dr.Myra Klienpeter专访
国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

 编辑:国际循环网 时间:2010/5/21 12:44:00    加入收藏
 关键字:Myra Klienpeter ASH2010 

  《国际循环》:能否为我们介绍下哪些患者适合应用CCB?
    Myra Klienpeter:在ACCORD试验的强化降压组,更多患者应用了CCB。对于单纯收缩期高血压患者,我倾向于更多应用CCB。目前上市的单片复方制剂中,有很多含有长效CCB氨氯地平,应用这种单片复方制剂的患者能够较快地将血压降下来,有助于血压达标。

    <International Circulation>: Could you extend this on what patients you would prefer to use calcium channel blockers for?
    Dr Myra Klienpeter: In the intensive therapy of the ACCORD trial there was more calcium channel blocker usage.  In those patients with isolated systolic hypertension I tend to use more calcium channel blockers. A lot of the combination medication being brought into the market in which long standing calcium channel blocker amlodipine is added to the drug and those patients  are able to achieve a low blood pressure in a relatively rapid fashion and help them reach their blood pressure goals.



上一页  [1]  [2]  [3]  [4]  [5]  下一页

注册

网友评论仅供其表达个人看法,并不表明国际循环同意其观点或证实其描述。 发表评论需登陆

点击排行 Top Hits

相关文章

相关幻灯

相关视频

 
关于本站 | 设为首页 | 加入收藏 | 站长邮箱 | 友情链接 | 版权申明

国际循环 版权所有  2008-2021 icirculation.com  All Rights Reserved